(19)
(11) EP 3 243 517 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
published in accordance with Art. 153(4) EPC

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
14.11.2018 Bulletin 2018/46

(43) Date of publication:
15.11.2017 Bulletin 2017/46

(21) Application number: 16735024.8

(22) Date of filing: 05.01.2016
(51) International Patent Classification (IPC): 
A61K 33/24(2006.01)
A23L 33/16(2016.01)
A61K 33/00(2006.01)
A61K 33/26(2006.01)
A61K 33/38(2006.01)
A61P 1/04(2006.01)
A61P 3/04(2006.01)
A61P 3/10(2006.01)
A61P 9/12(2006.01)
A61P 25/28(2006.01)
A23L 2/52(2006.01)
A61K 8/29(2006.01)
A61K 33/22(2006.01)
A61K 33/34(2006.01)
A61P 1/02(2006.01)
A61P 1/16(2006.01)
A61P 3/06(2006.01)
A61P 9/10(2006.01)
A61P 17/00(2006.01)
A61P 25/32(2006.01)
(86) International application number:
PCT/JP2016/050106
(87) International publication number:
WO 2016/111285 (14.07.2016 Gazette 2016/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.01.2015 JP 2015001176
20.08.2015 JP 2015162792

(71) Applicants:
  • Yamada, Osamu
    Takatsuki-shi, Osaka 569-0002 (JP)
  • OSU Corporation
    Takatsuki-shi, Osaka 569-0002 (JP)

(72) Inventors:
  • YAMADA, Osamu
    Takatsuki-sho, Osaka 5690002 (JP)
  • MARUO, Junpei
    Higashiosaka-shi Osaka 579-8032 (JP)

(74) Representative: Rigamonti, Dorotea 
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)


(56) References cited: : 
   
       


    (54) MEDICINAL COMPOSITION, BLOOD TREATMENT DEVICE, COSMETIC, FOOD AND DRINK USING COMBUSTION SYNTHESIS MATERIAL


    (57) Disclosed are a pharmaceutical composition, cosmetic product, and food or drink product each comprising a porous ceramic obtained by combustion synthesis of a starting material comprising (1) titanium and (2) at least one member selected from the group consisting of carbon, boron, nitrogen, and silicon; a pharmaceutical composition and cosmetic product each comprising a radical- and nanobubble-containing liquid; and a blood treatment device comprising a blood flow channel for extracorporeal circulation of a patient's blood, the blood flow channel being provided with the porous ceramic above, and the porous ceramic and the blood are brought into contact with each other.